nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—Parkinson's disease	0.902	1	CbGaD
Alfentanil—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000135	0.00139	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000135	0.00138	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAG—Parkinson's disease	0.000135	0.00138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000133	0.00136	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000133	0.00136	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000132	0.00135	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.00013	0.00133	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.000129	0.00132	CbGpPWpGaD
Alfentanil—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000124	0.00127	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000123	0.00125	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000121	0.00124	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000121	0.00123	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00012	0.00123	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000116	0.00119	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—DBH—Parkinson's disease	0.000116	0.00119	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.000116	0.00119	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GBA—Parkinson's disease	0.000116	0.00119	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000115	0.00118	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000115	0.00118	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000115	0.00118	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000115	0.00117	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000113	0.00116	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000111	0.00113	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000111	0.00113	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—TNF—Parkinson's disease	0.00011	0.00113	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00011	0.00113	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000109	0.00112	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000104	0.00106	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000104	0.00106	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000103	0.00106	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000101	0.00104	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000101	0.00103	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000101	0.00103	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.0001	0.00102	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	9.86e-05	0.00101	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	9.84e-05	0.00101	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	9.65e-05	0.000988	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.62e-05	0.000984	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.57e-05	0.000979	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ND3—Parkinson's disease	9.53e-05	0.000975	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MCCC1—Parkinson's disease	9.53e-05	0.000975	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.44e-05	0.000966	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GCH1—Parkinson's disease	9.41e-05	0.000962	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	9.35e-05	0.000956	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	9.08e-05	0.000929	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	9.02e-05	0.000922	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TALDO1—Parkinson's disease	8.96e-05	0.000916	CbGpPWpGaD
Alfentanil—ALB—Metabolism—OMD—Parkinson's disease	8.96e-05	0.000916	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	8.94e-05	0.000914	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—IL6—Parkinson's disease	8.88e-05	0.000909	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	8.86e-05	0.000906	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	8.77e-05	0.000897	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	8.74e-05	0.000894	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.73e-05	0.000893	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PENK—Parkinson's disease	8.55e-05	0.000874	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAG—Parkinson's disease	8.55e-05	0.000874	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—DDC—Parkinson's disease	8.51e-05	0.000871	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—FGB—Parkinson's disease	8.51e-05	0.000871	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NDUFB11—Parkinson's disease	8.49e-05	0.000869	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	8.49e-05	0.000868	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	8.46e-05	0.000865	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	8.46e-05	0.000865	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.43e-05	0.000862	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—FBP1—Parkinson's disease	8.39e-05	0.000858	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GBA—Parkinson's disease	8.39e-05	0.000858	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—DBH—Parkinson's disease	8.39e-05	0.000858	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—TNF—Parkinson's disease	8.35e-05	0.000854	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MCCC1—Parkinson's disease	8.35e-05	0.000854	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ND3—Parkinson's disease	8.35e-05	0.000854	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GCH1—Parkinson's disease	8.1e-05	0.000829	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTA4—Parkinson's disease	8.04e-05	0.000823	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.93e-05	0.000811	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.93e-05	0.000811	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.9e-05	0.000808	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.88e-05	0.000806	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TALDO1—Parkinson's disease	7.85e-05	0.000803	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—OMD—Parkinson's disease	7.85e-05	0.000803	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.82e-05	0.0008	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	7.82e-05	0.0008	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.79e-05	0.000797	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	7.76e-05	0.000794	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	7.68e-05	0.000785	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	7.68e-05	0.000785	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NDUFB11—Parkinson's disease	7.44e-05	0.000761	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	7.35e-05	0.000752	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	7.31e-05	0.000748	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	7.27e-05	0.000743	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.26e-05	0.000742	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	7.24e-05	0.000741	CbGpPWpGaD
Alfentanil—ALB—Metabolism—FBP1—Parkinson's disease	7.22e-05	0.000739	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GBA—Parkinson's disease	7.22e-05	0.000739	CbGpPWpGaD
Alfentanil—ALB—Metabolism—DBH—Parkinson's disease	7.22e-05	0.000739	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MAOB—Parkinson's disease	7.17e-05	0.000733	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.16e-05	0.000732	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCH1—Parkinson's disease	7.1e-05	0.000726	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	7.06e-05	0.000722	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	6.77e-05	0.000692	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	6.37e-05	0.000652	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GBA—Parkinson's disease	6.33e-05	0.000647	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—FBP1—Parkinson's disease	6.33e-05	0.000647	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—DBH—Parkinson's disease	6.33e-05	0.000647	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SOD1—Parkinson's disease	6.32e-05	0.000647	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.31e-05	0.000645	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	6.18e-05	0.000632	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—DDC—Parkinson's disease	6.15e-05	0.00063	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	6.15e-05	0.000629	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.06e-05	0.00062	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—ABL1—Parkinson's disease	6.03e-05	0.000617	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF2—Parkinson's disease	6e-05	0.000614	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.92e-05	0.000606	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTA4—Parkinson's disease	5.81e-05	0.000595	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INSR—Parkinson's disease	5.7e-05	0.000583	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HGF—Parkinson's disease	5.67e-05	0.00058	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.67e-05	0.00058	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.53e-05	0.000566	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGB—Parkinson's disease	5.39e-05	0.000551	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	5.38e-05	0.00055	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	5.36e-05	0.000549	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	5.33e-05	0.000545	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.31e-05	0.000543	CbGpPWpGaD
Alfentanil—ALB—Metabolism—DDC—Parkinson's disease	5.3e-05	0.000542	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	5.28e-05	0.00054	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.27e-05	0.000539	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	5.23e-05	0.000535	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CTGF—Parkinson's disease	5.23e-05	0.000535	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.21e-05	0.000533	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MAOB—Parkinson's disease	5.18e-05	0.00053	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	5.18e-05	0.00053	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ND3—Parkinson's disease	5.14e-05	0.000526	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.14e-05	0.000526	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.06e-05	0.000517	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	5.02e-05	0.000513	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTA4—Parkinson's disease	5.01e-05	0.000512	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.94e-05	0.000506	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	4.87e-05	0.000498	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.84e-05	0.000495	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—OMD—Parkinson's disease	4.84e-05	0.000495	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NQO1—Parkinson's disease	4.82e-05	0.000493	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TH—Parkinson's disease	4.75e-05	0.000486	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	4.68e-05	0.000479	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—DDC—Parkinson's disease	4.64e-05	0.000475	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.61e-05	0.000472	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.59e-05	0.000469	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYCS—Parkinson's disease	4.56e-05	0.000466	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	4.54e-05	0.000464	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	4.54e-05	0.000464	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLA2G6—Parkinson's disease	4.51e-05	0.000461	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MAOB—Parkinson's disease	4.46e-05	0.000456	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.39e-05	0.000449	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.37e-05	0.000447	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.25e-05	0.000434	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.12e-05	0.000422	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—COMT—Parkinson's disease	4.04e-05	0.000413	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—Parkinson's disease	4.02e-05	0.000411	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MAOA—Parkinson's disease	4.01e-05	0.00041	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—Parkinson's disease	3.96e-05	0.000405	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.95e-05	0.000404	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MAOB—Parkinson's disease	3.91e-05	0.0004	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.9e-05	0.000399	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DBH—Parkinson's disease	3.9e-05	0.000399	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GBA—Parkinson's disease	3.9e-05	0.000399	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	3.85e-05	0.000394	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.8e-05	0.000389	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	3.8e-05	0.000389	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.78e-05	0.000387	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—Parkinson's disease	3.69e-05	0.000378	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.68e-05	0.000376	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	3.63e-05	0.000371	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GPX1—Parkinson's disease	3.54e-05	0.000362	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.52e-05	0.00036	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.48e-05	0.000356	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TH—Parkinson's disease	3.43e-05	0.000351	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NGF—Parkinson's disease	3.34e-05	0.000341	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2D6—Parkinson's disease	3.32e-05	0.000339	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.29e-05	0.000337	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—Parkinson's disease	3.26e-05	0.000334	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CTGF—Parkinson's disease	3.25e-05	0.000333	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.18e-05	0.000325	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—Parkinson's disease	3.04e-05	0.000311	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—Parkinson's disease	3.03e-05	0.00031	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NQO1—Parkinson's disease	3e-05	0.000307	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TH—Parkinson's disease	2.96e-05	0.000302	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—Parkinson's disease	2.95e-05	0.000302	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—COMT—Parkinson's disease	2.92e-05	0.000298	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.91e-05	0.000297	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.9e-05	0.000297	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.9e-05	0.000296	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.86e-05	0.000293	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DDC—Parkinson's disease	2.86e-05	0.000293	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CTGF—Parkinson's disease	2.85e-05	0.000292	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYCS—Parkinson's disease	2.84e-05	0.00029	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.75e-05	0.000281	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.7e-05	0.000276	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.67e-05	0.000273	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.66e-05	0.000272	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NQO1—Parkinson's disease	2.63e-05	0.000269	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INS—Parkinson's disease	2.6e-05	0.000265	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TH—Parkinson's disease	2.59e-05	0.000265	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.56e-05	0.000261	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INS—Parkinson's disease	2.52e-05	0.000258	CbGpPWpGaD
Alfentanil—ALB—Metabolism—COMT—Parkinson's disease	2.51e-05	0.000257	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—Parkinson's disease	2.5e-05	0.000256	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MAOA—Parkinson's disease	2.5e-05	0.000255	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYCS—Parkinson's disease	2.49e-05	0.000254	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—Parkinson's disease	2.47e-05	0.000252	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.43e-05	0.000249	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.41e-05	0.000246	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—Parkinson's disease	2.37e-05	0.000242	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.36e-05	0.000241	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—Parkinson's disease	2.3e-05	0.000235	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—COMT—Parkinson's disease	2.2e-05	0.000225	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPX1—Parkinson's disease	2.2e-05	0.000225	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—Parkinson's disease	2.2e-05	0.000225	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.19e-05	0.000224	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MAOA—Parkinson's disease	2.19e-05	0.000224	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.16e-05	0.000221	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—Parkinson's disease	2.03e-05	0.000208	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.01e-05	0.000206	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPX1—Parkinson's disease	1.93e-05	0.000197	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—Parkinson's disease	1.89e-05	0.000193	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.88e-05	0.000192	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INS—Parkinson's disease	1.88e-05	0.000192	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.87e-05	0.000191	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.79e-05	0.000183	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.78e-05	0.000182	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.76e-05	0.00018	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.73e-05	0.000177	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—Parkinson's disease	1.66e-05	0.000169	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.64e-05	0.000167	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.62e-05	0.000166	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INS—Parkinson's disease	1.62e-05	0.000165	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TH—Parkinson's disease	1.6e-05	0.000163	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.53e-05	0.000157	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INS—Parkinson's disease	1.42e-05	0.000145	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—COMT—Parkinson's disease	1.36e-05	0.000139	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.35e-05	0.000138	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.35e-05	0.000138	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.33e-05	0.000136	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.28e-05	0.000131	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.24e-05	0.000127	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.19e-05	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—Parkinson's disease	1.1e-05	0.000113	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.1e-05	0.000112	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—Parkinson's disease	1.02e-05	0.000104	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INS—Parkinson's disease	8.72e-06	8.92e-05	CbGpPWpGaD
